- Community-Beiträge
- Aktuellste Threads
| Geld/Brief | 2,84 $ / 3,46 $ |
| Spread | +21,83% |
| Schluss Vortag | 3,53 $ |
| Gehandelte Stücke | 106.880 |
| Tagesvolumen Vortag | 274.552,0 $ |
| Tagestief 3,21 $ Tageshoch 3,53 $ | |
| 52W-Tief 2,025 $ 52W-Hoch 7,13 $ | |
| Jahrestief 2,025 $ Jahreshoch 5,54 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -23,51 $ |
| Jahresüberschuss in Mio. | -30,84 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -0,48 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -157,87% |
| Marktkapitalisierung in Mio. | 314,65 $ |
| KGV (Kurs/Gewinn) | -8,67 |
| KBV (Kurs/Buchwert) | - |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | -646,09% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 3,07 $ | - | - | 11.08.26 | |
| Düsseldorf | 2,90 € | +3,57% | 2,80 € | 14.08.26 | |
| Frankfurt | 2,80 € | +3,70% | 2,70 € | 14.08.26 | |
| Gettex | 2,98 € | -1,32% | 3,02 € | 14.08.26 | |
| L&S RT | 2,97 € | 0 % | 2,97 € | 13:04 | |
| München | 3,00 € | +9,49% | 2,74 € | 14.08.26 | |
| Nasdaq | 3,46 $ | -1,98% | 3,53 $ | 14.08.26 | |
| NYSE | 3,445 $ | -2,82% | 3,545 $ | 14.08.26 | |
| Quotrix | 3,06 € | +11,68% | 2,74 € | 14.08.26 | |
| Stuttgart | 2,94 € | -2,00% | 3,00 € | 14.08.26 | |
| Tradegate | 2,84 € | -7,79% | 3,08 € | 14.08.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 14.08.26 | 3,46 | 275 T |
| 13.08.26 | 3,535 | 0,52 M |
| 12.08.26 | 3,14 | 95 T |
| 11.08.26 | 3,13 | 110 T |
| 10.08.26 | 3,11 | 231 T |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 3,45 $ | +0,29% |
| 1 Monat | 5,34 $ | -35,21% |
| 6 Monate | 2,76 $ | +25,36% |
| 1 Jahr | 3,76 $ | -7,98% |
| 5 Jahre | 3,38 $ | +2,37% |
| Marktkapitalisierung | 314,65 Mio. $ |
| Streubesitz | 11,27% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +3,41% | Vanguard Group Inc |
| +2,99% | Vanguard Capital Management, LLC |
| +2,31% | Vanguard Morn Total Stk Mkt Idx Investor |
| +2,12% | Vanguard Total Stock Mkt Idx Inv |
| +1,98% | Advisor Group Holdings, Inc. |
| +1,45% | iShares Russell 2000 ETF |
| +1,39% | BlackRock Inc |
| +1,17% | Jane Street Group LLC |
| +1,04% | Geode Capital Management, LLC |
| +0,86% | Marshall Wace Asset Management Ltd |
| +0,85% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,75% | Sontag Advisory LLC |
| +0,71% | Two Sigma Investments LLC |
| +0,66% | Geneos Wealth Management Inc |
| +0,57% | LPL Financial Corp |
| +0,56% | Commonwealth Equity Services, LLC |
| +0,48% | The Goldman Sachs Group Inc |
| +0,47% | iShares Russell 2000 Growth ETF |
| +0,46% | Vanguard Fiduciary Trust Co |
| +0,45% | Commonwealth Equity Services Inc |
| +0,44% | Russell 2000 Equity Index Fund B |
| +0,44% | Russell 2000 Index Non-Lendable Fund |
| +0,44% | Citadel Advisors Llc |
| +0,42% | Vanguard Russell 2000 ETF |
| +0,42% | Fidelity Extended Market Index |
| +0,33% | Morgan Stanley - Brokerage Accounts |
| +0,31% | State Street Corp |
| +0,31% | Sovran Advisors, LLC |
| +0,30% | Susquehanna International Group, LLP |
| +0,27% | State St Russell Sm Cap® Idx SL Cl I |
| +0,27% | Vivaldi Capital Management, LLC |
| +0,26% | UBS Group AG |
| +0,25% | 683 Capital Management LLC |
| +0,25% | RETIREMENT GUYS FORMULA LLC |
| +0,23% | Millennium Management LLC |
| +0,22% | Wellington Management Company LLP |
| +0,22% | Soltis Investment Advisors, LLC |
| +0,20% | Blackrock Extended Mkt Fund CF |
| +0,19% | Extended Equity Market Fund B |
| +0,19% | Extended Equity Market Fund E |
| +0,19% | CAMBRIDGE Invest RESEARCH ADVISORS, INC. |
| +0,19% | Northern Trust Corp |
| +0,18% | Schwab Small Cap Index |
| +0,17% | iShares Russell 2000 Value ETF |
| +0,17% | BlackRock Extended Equity Market Fund K |
| +0,16% | NT R2000 Index Fund - NL |
| +0,16% | FORTIS CAPITAL ADVISORS, LLC |
| +0,16% | iShares Micro-Cap ETF |
| +0,14% | NT R2000 Index Fund - DC - NL - 3 |
| +0,14% | Fidelity Total Market Index |
| +0,14% | Extended Equity Market Fund K |
| +0,12% | Russell 2500™ Index Fund F |
| +0,12% | Fidelity Nasdaq Composite ETF |
| +0,11% | Fidelity Series Total Market Index |
| +0,11% | Fidelity Nasdaq Composite Index |
| +0,10% | BlackRock Global Equity Mkt Netrl Instl |
| +0,10% | Spartan Extended Market Index Pool F |
| +0,09% | NT Ext Equity Mkt Index Fund - Lending |
| +0,09% | NT Ext Equity Mkt Idx Fd - L |
| +0,09% | Northern Trust Extended Eq Market Idx |
| +0,08% | NT Ext Equity Mkt Index Fund - NL |
| +0,08% | Horizon Kinetics Medical ETF |
| +0,06% | Vanguard Instl Ttl Stck Mkt Index Trust |
| +0,06% | NT Ext Equity Mkt Idx Fd - NL |
| +0,06% | Vanguard Instl Ttl Stck Mkt Idx Tr |
| +0,05% | Schwab Total Stock Market Index |
| +0,05% | Spartan Total Market Index Pool G |
| +0,05% | NT Ext Equity Mkt Idx Fd - DC - NL - T2 |
| +0,04% | Vanguard Balanced Index Inv |
| +0,04% | Vanguard Instl Ttl Stk Mkt Idx InstlPls |
| +0,03% | Vanguard U.S. Eq Idx £ Acc |
| +16,37% | Institutionelle Aktionäre |
| +11,27% | Streubesitz |
| -5,10% | Individuelle Aktionäre |
MK 103 Mio. $; bei 36 Mio. $ Cash und einem Cashburn von ~8 Mio. $ pro Quartal. Da zuckt bei mir noch nicht mal der kleine Finger.
"The Company believes it has sufficient cash to fund currently planned operations and research and development activities through at least March 31, 2023."
https://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-reports-financial-results-quarter-ended-3
